Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.215
-0.035 (-1.08%)
At close: Aug 26, 2025, 4:00 PM
3.190
-0.025 (-0.78%)
After-hours: Aug 26, 2025, 7:55 PM EDT
Grace Therapeutics Employees
Grace Therapeutics had 6 employees as of March 31, 2025. The number of employees increased by 2 or 50.00% compared to the previous year.
Employees
6
Change (1Y)
2
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,718,833
Market Cap
44.46M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 6 | 2 | 50.00% |
Mar 31, 2024 | 4 | -28 | -87.50% |
Mar 31, 2020 | 32 | 4 | 14.29% |
Mar 31, 2019 | 28 | 17 | 154.55% |
Feb 29, 2016 | 11 | 4 | 57.14% |
Feb 28, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GRCE News
- 14 days ago - Grace Therapeutics Announces First Quarter 2026 Financial Results, Provides Business Update - GlobeNewsWire
- 2 months ago - Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104 - GlobeNewsWire
- 2 months ago - Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update - GlobeNewsWire
- 2 months ago - Grace Therapeutics to Participate in the 2025 BIO International Conference - GlobeNewsWire
- 4 months ago - Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104 - GlobeNewsWire
- 6 months ago - Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - GlobeNewsWire
- 6 months ago - Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 6 months ago - Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update - GlobeNewsWire